Related Experiment Video
Updated: Jun 14, 2026
09:15
Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model
Published on: October 10, 2017
Bioengineered skin in diabetic foot ulcers.
1First Hospital of Lanzhou University, Lanzhou city, Gansu province, 730000, China.
Diabetes, Obesity & Metabolism
|April 13, 2010
Summary
Bioengineered skin (BS) offers significant advantages for treating diabetic foot ulcers (DFUs). This meta-analysis confirms BS is more effective and safer than conventional treatments, with a lower infection risk.
Area of Science:
- Regenerative Medicine
- Wound Healing
- Dermatology
Background:
- Diabetic foot ulcers (DFUs) pose a significant clinical challenge.
- The efficacy of bioengineered skin (BS) in DFU treatment requires further clarification.
Purpose of the Study:
- To conduct a meta-analysis of randomized controlled trials (RCTs).
- To determine the effectiveness and safety of BS compared to conventional treatment (CT) for DFUs.
Main Methods:
- Systematic literature search across electronic databases for RCTs.
- Inclusion criteria focused on BS versus CT for DFU management.
- Outcomes assessed included wound closure, complications, recurrence, and adverse events.
Main Results:
- Seven RCTs involving 880 participants were analyzed.
- BS demonstrated significant advantages in effectiveness and safety over CT for DFUs.
- Infection was the only complication with a statistically significant difference, favoring BS.
Conclusions:
- Bioengineered skin (BS) shows promise for DFU treatment.
- BS offers superior effectiveness and safety compared to conventional therapies.
- Reduced infection risk is a key benefit of BS in DFU management.
Related Concept Videos
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...